SCHEMBL105486

Kakonein is a lipid of Polyketides (PK) class. Kakonein is associated with abnormalities such as Fatty Liver, Chronic liver disease, Morphologically altered structure, Hypertensive disease and Cardiovascular Diseases. The involved functions are known as protein expression, Extravasation, Liver damage, mRNA Expression and cell activation. Kakonein often locates in Body tissue, Hepatic, Microvilli, Cytoplasm and Membrane. The associated genes with Kakonein are TJP1 gene, CD14 gene, iberiotoxin, AT-Rich Interactive Domain-Containing Protein 1A and NKS1 gene. The related lipids are dehydrosoyasaponin I and Steroids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of SCHEMBL105486, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with SCHEMBL105486?

SCHEMBL105486 is suspected in Chronic liver disease, Hypertensive disease, Cardiovascular Diseases, Myocardial Infarction, Cerebrovascular accident, Fatty Liver and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with SCHEMBL105486

MeSH term MeSH ID Detail
Liver Cirrhosis D008103 67 associated lipids
Memory Disorders D008569 33 associated lipids
Parkinson Disease D010300 53 associated lipids
Urinary Incontinence D014549 4 associated lipids
Reperfusion Injury D015427 65 associated lipids
Glucose Intolerance D018149 13 associated lipids
Alcohol-Related Disorders D019973 3 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Per page 10 20 50 | Total 43

PubChem Associated disorders and diseases

What pathways are associated with SCHEMBL105486

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with SCHEMBL105486?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with SCHEMBL105486?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with SCHEMBL105486?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with SCHEMBL105486?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with SCHEMBL105486?

Knock-out

Knock-out are used in the study 'MATE2 mediates vacuolar sequestration of flavonoid glycosides and glycoside malonates in Medicago truncatula.' (Zhao J et al., 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with SCHEMBL105486

Download all related citations
Per page 10 20 50 100 | Total 919
Authors Title Published Journal PubMed Link
Hou SZ et al. Role of the interaction between puerarin and the erythrocyte membrane in puerarin-induced hemolysis. 2011 Chem. Biol. Interact. pmid:21453687
Qi H et al. Optimization and physicochemical characterization of thermosensitive poloxamer gel containing puerarin for ophthalmic use. 2006 Chem. Pharm. Bull. pmid:17077546
Yu Z et al. Simultaneous determination of components in preparation Naodesheng injection by high performance liquid chromatograph-atmospheric pressure chemical ionization mass spectrometry (HPLC-MS/APCI). 2006 Chem. Pharm. Bull. pmid:16595973
Nakamura K et al. The C-glucosyl bond of puerarin was cleaved hydrolytically by a human intestinal bacterium strain PUE to yield its aglycone daidzein and an intact glucose. 2011 Chem. Pharm. Bull. pmid:21212542
Yue PF et al. Development and optimization of intravenous puerarin emulsions formation by a novel complex-phase inversion-homogenization technology. 2007 Chem. Pharm. Bull. pmid:17978512
Quan DQ et al. Studies on preparation and absolute bioavailability of a self-emulsifying system containing puerarin. 2007 Chem. Pharm. Bull. pmid:17473473
Zhang CL et al. Comparative study of Puerariae lobatae and Puerariae thomsonii by HPLC-diode array detection-flow injection-chemiluminescence coupled with HPLC-electrospray ionization-MS. 2011 Chem. Pharm. Bull. pmid:21532189
Wu HQ et al. Protective effects and mechanism of puerarin on learning-memory disorder after global cerebral ischemia-reperfusion injury in rats. 2009 Chin J Integr Med pmid:19271171
Liu Y et al. Induction of adhesion molecule expression in co-culture of human bronchial epithelial cells and neutrophils suppressed by puerarin via down-regulating p38 mitogen-activated protein kinase and nuclear factor κB pathways. 2014 Chin J Integr Med pmid:24122632
Zhang MY et al. In vitro and in vivo effects of puerarin on promotion of osteoblast bone formation. 2012 Chin J Integr Med pmid:22457138
Pang W et al. Effect of puerarin on the release of interleukin-8 in co-culture of human bronchial epithelial cells and neutrophils. 2012 Chin J Integr Med pmid:22457139
Zhao Y and Zhou Y Puerarin improve insulin resistance of adipocyte through activating Cb1 binding protein path. 2012 Chin J Integr Med pmid:22457141
Li SW et al. Comparison on Anticoagulation and Antiplatelet Aggregation Effects of Puerarin with Heparin Sodium and Tirofiban Hydrochloride: An In Vitro Study. 2018 Chin J Integr Med pmid:29067595
Wang HQ et al. Puerarin Up-regulates Methyl-CpG Binding Protein 2 Phosphorylation in Hippocampus of Vascular Dementia Rats. 2018 Chin J Integr Med pmid:29327124
Kong H et al. Effect of Puerarin on the Pharmacokinetics of Baicalin in Gegen Qinlian Decoction () in Mice. 2018 Chin J Integr Med pmid:25908218
Yuan SY et al. Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro. 2016 Chin J Nat Med pmid:27114313
Liu AC et al. Pre-treatment with puerarin affects pharmacokinetics of warfarin, but not clopidogrel, in experimental rats. 2015 Chin J Nat Med pmid:25908622
Wang C et al. The proliferation, differentiation, and mineralization effects of puerarin on osteoblasts in vitro. 2014 Chin J Nat Med pmid:24969524
Chen G et al. Puerarin attenuates angiotensin II-induced cardiac fibroblast proliferation via the promotion of catalase activity and the inhibition of hydrogen peroxide-dependent Rac-1 activation. 2018 Chin J Nat Med pmid:29425589
Liu AC et al. LC-MS/MS method for the determination of a new puerarin derivative and its application in pharmacokinetic studies in rats. 2013 Chin J Nat Med pmid:24359785